Heart Beat: Research continues to serve up heart perks for coffee drinkers
Evidence of coffee’s cardiovascular benefits continues to accrue.
Content restricted. Requires subscription
Trial clouds use of niacin with a statin
A clinical trial of niacin in combination with a statin to lower cholesterol was stopped early because of safety concerns.
Content restricted. Requires subscription
Sliding scale for LDL: How low should you go?
Research has lowered the target for the level of “bad” LDL cholesterol, but an individual’s cardiovascular risk should factor into determining the appropriate target.
Content restricted. Requires subscription
Ask the doctor: What should I do about high triglycerides?
On my last blood test, my triglycerides were 280. Should I be worried about that? My doctor wants me to start taking something called Lopid. Is there another solution?
Content restricted. Requires subscription
Heart Beat: No connection between ARBs and cancer
The Food and Drug Administration has concluded that angiotensin-receptor blocker medications used to treat high blood pressure do not increase the risk of developing lung cancer.
Content restricted. Requires subscription
On call: Dietary guidelines and caloric percentages
I really appreciate the dietary guidelines that you publish from time to time, but my wife and I find it hard to do the math in a busy supermarket. Can you give us targets that are easier to use than “percentages of daily calories”
Content restricted. Requires subscription
Medical memo: Semen quality and survival
A long-term Danish study correlates a higher sperm count with a lower mortality rate.
Content restricted. Requires subscription
Correction
Our April 2011 article “Meet the statins” contained an error.
Content restricted. Requires subscription
Aiming for ideal improves heart health
The American Heart Association hopes that its definition of ideal cardiovascular health will encourage people to strive to be healthier.
Content restricted. Requires subscription
Niacin trial stopped early: Now what?
A clinical trial of niacin in combination with a statin to lower cholesterol was stopped early because of concerns that the combined medication could be associated with an increased risk of stroke.
Content restricted. Requires subscription